608 related articles for article (PubMed ID: 16720629)
1. Recombinant human follicle-stimulating hormone alters maternal ovarian hormone concentrations and the uterus and perturbs fetal development in mice.
Kelley RL; Kind KL; Lane M; Robker RL; Thompson JG; Edwards LJ
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E761-70. PubMed ID: 16720629
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human follicle stimulating hormone on follicle development and ovulation in the mare.
Tharasanit T; Colenbrander B; Bevers MM; Stout TA
Theriogenology; 2006 Apr; 65(6):1071-81. PubMed ID: 16153704
[TBL] [Abstract][Full Text] [Related]
3. Follicle-stimulating hormone regulates steroidogenic enzymes in cultured cells of the chick embryo ovary.
Gómez Y; Velázquez PN; Peralta-Delgado I; Méndez MC; Vilchis F; Juárez-Oropeza MA; Pedernera E
Gen Comp Endocrinol; 2001 Mar; 121(3):305-15. PubMed ID: 11254372
[TBL] [Abstract][Full Text] [Related]
4. The effects of GnRH analogue (buserelin) or hCG (Chorulon) on Day 12 of pregnancy on ovarian function, plasma hormone concentrations, conceptus growth and placentation in ewes and ewe lambs.
Khan TH; Beck NF; Khalid M
Anim Reprod Sci; 2007 Dec; 102(3-4):247-57. PubMed ID: 17174489
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human follicle-stimulating hormone on embryo development in mice.
Edwards LJ; Kind KL; Armstrong DT; Thompson JG
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E845-51. PubMed ID: 15598671
[TBL] [Abstract][Full Text] [Related]
6. Effects of urinary and recombinant gonadotrophins on gene expression profiles during the murine peri-implantation period.
Sibug RM; Datson N; Tijssen AM; Morsink M; de Koning J; de Kloet ER; Helmerhorst FM
Hum Reprod; 2007 Jan; 22(1):75-82. PubMed ID: 17053000
[TBL] [Abstract][Full Text] [Related]
7. [Effect of estradiol supplementation during the luteal phase on mouse endometrial expression of leukaemia inhibitory factor and pinopodes in controlled ovarian stimulation cycles].
Zhang CL; Xie JK; Zhang SD; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):937-41. PubMed ID: 19134335
[TBL] [Abstract][Full Text] [Related]
8. The effect of hyperstimulation on transforming growth factor beta(1) and beta(2) in the rat uterus: possible consequences for embryo implantation.
Jovanović A; Kramer B
Fertil Steril; 2010 Mar; 93(5):1509-17. PubMed ID: 19200954
[TBL] [Abstract][Full Text] [Related]
9. Endometrial and conceptus expression of HoxA10, transforming growth factor beta1, leukemia inhibitory factor, and prostaglandin H synthase-2 in early pregnant pigs with gonadotropin-induced estrus.
Blitek A; Kaczmarek MM; Kiewisz J; Ziecik AJ
Domest Anim Endocrinol; 2010 May; 38(4):222-34. PubMed ID: 20022444
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-acting recombinant human follicle-stimulating hormone analogs containing N-linked glycosylation on murine folliculogenesis.
Ruman JI; Pollak S; Trousdale RK; Klein J; Lustbader JW
Fertil Steril; 2005 Apr; 83 Suppl 1():1303-9. PubMed ID: 15831306
[TBL] [Abstract][Full Text] [Related]
11. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.
Fábregues F; Creus M; Peñarrubia J; Manau D; Vanrell JA; Balasch J
Fertil Steril; 2006 Apr; 85(4):925-31. PubMed ID: 16580376
[TBL] [Abstract][Full Text] [Related]
13. Human chorionic gonadotropin or human recombinant follicle-stimulating hormone (FSH)-induced ovulation and subsequent fertilization and early embryo development in hypophysectomized FSH-primed mice.
Wang XN; Greenwald GS
Endocrinology; 1993 May; 132(5):2009-16. PubMed ID: 8477652
[TBL] [Abstract][Full Text] [Related]
14. A single-chain tetradomain glycoprotein hormone analog elicits multiple hormone activities in vivo.
Garcia-Campayo V; Boime I; Ma X; Daphna-Iken D; Kumar TR
Biol Reprod; 2005 Feb; 72(2):301-8. PubMed ID: 15385421
[TBL] [Abstract][Full Text] [Related]
15. Graft site and gonadotrophin stimulation influences the number and quality of oocytes from murine ovarian tissue grafts.
Yang HY; Cox SL; Jenkin G; Findlay J; Trounson A; Shaw J
Reproduction; 2006 May; 131(5):851-9. PubMed ID: 16672350
[TBL] [Abstract][Full Text] [Related]
16. Ovarian stimulation using human chorionic gonadotrophin impairs blastocyst implantation and decidualization by altering ovarian hormone levels and downstream signaling in mice.
Ezoe K; Daikoku T; Yabuuchi A; Murata N; Kawano H; Abe T; Okuno T; Kobayashi T; Kato K
Mol Hum Reprod; 2014 Nov; 20(11):1101-16. PubMed ID: 25122188
[TBL] [Abstract][Full Text] [Related]
17. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
18. Highly expressed recombinant human follicle-stimulating hormone from Chinese hamster ovary cells grown in serum-free medium and its effect on induction of folliculogenesis and ovulation.
Kim DJ; Seok SH; Baek MW; Lee HY; Juhn JH; Lee S; Yun M; Park JH
Fertil Steril; 2010 May; 93(8):2652-60. PubMed ID: 19535048
[TBL] [Abstract][Full Text] [Related]
19. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice.
Ruan HC; Zhu XM; Luo Q; Liu AX; Qian YL; Zhou CY; Jin F; Huang HF; Sheng JZ
Hum Reprod; 2006 Oct; 21(10):2521-9. PubMed ID: 16790614
[TBL] [Abstract][Full Text] [Related]
20. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
